Aurobindo Pharma Subsidiary Eugia Pharma Receives USFDA Approval For Posaconazole Injection

Aurobindo Pharma Subsidiary Eugia Pharma Receives USFDA Approval For Posaconazole Injection

The product is expected to be launched in December 2023. The approved product has an estimated market size of US dollar 25.4 million for the twelve months ending October 2023, according to IQVIA.

FPJ Web DeskUpdated: Wednesday, December 27, 2023, 11:48 AM IST
article-image
Aurobindo Pharma Subsidiary Eugia Pharma Receives USFDA Approval For Posaconazole Injection | Image: Aurobindo Pharma (Representative)

Aurobindo Pharma Limited on Wednesday announced that its wholly owned subsidiary company, Eugia Pharma Specialities Limited, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Posaconazole Injection, 300 mg/16.7 mL (18 mg/mL), Single-Dose Vial, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Noxafil Injection, 300 mg/16.7 mL (18 mg/mL), of Merck Sharp & Dohme LLC (Merck), the company announced through an exchange filing.

The product is expected to be launched in December 2023. The approved product has an estimated market size of US dollar 25.4 million for the twelve months ending October 2023, according to IQVIA.

This is the 173rd ANDA approval (including 8 tentative approvals received) out of Eugia Pharma Specialities Group (EPSG) facilities, manufacturing both oral and sterile specialty products.

About Posaconazole Injection

Posaconazole Injection, 300 mg/16.7 mL (18 mg/mL), Single-Dose Vial is indicated forthe prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised, such as hematopoietic stem cell transplant (HSCT) recipients with graft-versushost disease (GVHD) or those with hematologic malignancies with prolonged neutropenia from chemotherapy.

Aurobindo Pharma Limited shares

The shares of Aurobindo Pharma Limited on Wednesday at 11:45 am IST were trading at Rs 1,073.55, up by 0.93 per cent.

RECENT STORIES

Punjab's GST Mop-Up Rises 16% To Over ₹19,000 Cr Till February

Punjab's GST Mop-Up Rises 16% To Over ₹19,000 Cr Till February

Bharat Textile Expo To Be An Annual Affair, Says AEPC Chairman

Bharat Textile Expo To Be An Annual Affair, Says AEPC Chairman

India's Used Car Market Size To Touch $100 Billion-Mark By 2034: CARS24 CEO

India's Used Car Market Size To Touch $100 Billion-Mark By 2034: CARS24 CEO

Outsourcing In Peril? BPO Employees Face Maximum Risk Of Getting Replaced By AI, Says Nasscom...

Outsourcing In Peril? BPO Employees Face Maximum Risk Of Getting Replaced By AI, Says Nasscom...

Viral Video: Mark Zuckerberg Amazed By Anant Ambani's 'Royal' Watch, Luxury Of Jamnagar

Viral Video: Mark Zuckerberg Amazed By Anant Ambani's 'Royal' Watch, Luxury Of Jamnagar